Global Cardiovascular Implants Market Professional Survey Report 2019
Cardiac disease is a condition that involves narrowing or blockage of blood vessels. Cardiac disease is caused due to heart rhythm problems, smoking, high cholesterol, and high blood pressure. Coronary artery disease, myocardial infarction, peripheral arterial disease, atherosclerosis, and heart failure are some of the major cardiac diseases. The contraction or obstruction of blood vessels, especially coronary arteries, is one of the most common reasons for cardiac diseases. Cardiovascular implants are widely used for the treatment of cardiac diseases.
The cardiac rhythm management devices segment is likely to expand at a rapid pace during the forecast period, due to increase in life expectancy and technological developments such as cardiac resynchronization therapy. Moreover, cardiac rhythm management devices are increasingly used for the management of arrhythmia and heart failure. In terms of end-user, the global market can be categorized into hospitals, ambulatory surgical centers, and research institutes. The hospitals segment is expected to expand at a high CAGR during the forecast period, as most patients prefer to visit hospitals for diagnosis and treatment. Moreover, larger number of cardiac implanted surgeries are conducted in hospitals. Prevalence of heart disorders and aging population are the major factors fueling the growth of the global cardiovascular implants market. Moreover, rise in awareness about these implants and established infrastructure are projected to drive the market during the forecast period. However, high cost of devices and stringent approval process are anticipated to restrain the market in the next few years.
The global Cardiovascular Implants market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Cardiovascular Implants volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cardiovascular Implants market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cardiovascular Implants in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cardiovascular Implants manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Abbott Laboratories
Boston Scientific
Medtronic
St. Jude Medical
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Coronary Stents
Peripheral Stents
Heart Valves
Implanted Cardiac Pacemakers
Implantable Cardioverter Defibrillator
Cardiac Resynchronization Therapy (CRT) Device
Segment by Application
Minimally Invasive Heart Surgery
Heart Valve Repair or Replacement
Cardiac Resynchronization Therapy (CRT)
Open Heart Surgery
Others
The cardiac rhythm management devices segment is likely to expand at a rapid pace during the forecast period, due to increase in life expectancy and technological developments such as cardiac resynchronization therapy. Moreover, cardiac rhythm management devices are increasingly used for the management of arrhythmia and heart failure. In terms of end-user, the global market can be categorized into hospitals, ambulatory surgical centers, and research institutes. The hospitals segment is expected to expand at a high CAGR during the forecast period, as most patients prefer to visit hospitals for diagnosis and treatment. Moreover, larger number of cardiac implanted surgeries are conducted in hospitals. Prevalence of heart disorders and aging population are the major factors fueling the growth of the global cardiovascular implants market. Moreover, rise in awareness about these implants and established infrastructure are projected to drive the market during the forecast period. However, high cost of devices and stringent approval process are anticipated to restrain the market in the next few years.
The global Cardiovascular Implants market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Cardiovascular Implants volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cardiovascular Implants market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cardiovascular Implants in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cardiovascular Implants manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Abbott Laboratories
Boston Scientific
Medtronic
St. Jude Medical
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Coronary Stents
Peripheral Stents
Heart Valves
Implanted Cardiac Pacemakers
Implantable Cardioverter Defibrillator
Cardiac Resynchronization Therapy (CRT) Device
Segment by Application
Minimally Invasive Heart Surgery
Heart Valve Repair or Replacement
Cardiac Resynchronization Therapy (CRT)
Open Heart Surgery
Others
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
